Fig. 3
From: Dapagliflozin in peritoneal dialysis patients: a pilot study evaluating peritoneal membrane function
Changes of Creatinine D/P after 30 days of treatment with Dapagliflozin in CAPD patients. Modified PET with 4.25% Dextrose was performed before and 30 days after the daily dose of 10 mg Dapagliflozin. After being treated with Dapagliflozin, 9 patients had a reduction of D/P (light blue) and 11 patients had an increase in D/P after treatment (dark blue). Change in D/P = [Post-treatment]—[Pre-treatment]. CAPD: Continuous Ambulatory Peritoneal Dialysis